Latka logo
Orbis Medicines logo

Orbis Medicinesrevenue

Frederiksberg, DenmarkFounded 2021CEO Maureen Brinkman

Orbis Medicines is a biotechnology company focused on pioneering a new era for oral macrocycle drug discovery.

orbismedicines.comLinkedInUpdated Sep 10, 2026
Annual revenue
$7.6M
Sep 2025EST
Employees
43
Sep 2025

Orbis Medicines revenue

Orbis Medicines has not published its revenue. Growjo puts it at about $7.6M a year (September 2025).

$0
$2M
$4M
$6M
$0
–
$7.6M
20212022–242025
ReportedEstimateFounded 2021 at $0; every reading has its own bar
As ofRevenueSource
Sep 2025$7.6MESTGrowjo estimate

Orbis Medicines CEO & employees

Maureen Brinkman is CEO of Orbis Medicines. Orbis Medicines has 43 employees (September 2025, LinkedIn).

0
20
40
43
2025
ReportedOne figure per year; a reported figure wins over an estimate

Orbis Medicines FAQ

What is Orbis Medicines' revenue?

Growjo estimates Orbis Medicines' revenue at about $7.6M a year (September 2025). The company hasn't published its own figure.

How many employees does Orbis Medicines have?

Orbis Medicines has 43 employees as of September 2025, according to LinkedIn.

Who is the CEO of Orbis Medicines?

Maureen Brinkman is the CEO of Orbis Medicines.

How this page is sourced

1 from public sources · 1 estimate. Founder figures link to the second they were said; public figures name their source; estimates are marked EST and say whose they are. Not financial advice.

Updated Sep 10, 2026Data disclaimerReport a correctionClaim this profileRun Orbis Medicines? Join the podcast